Global Vascular Co.
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $17M
Investors
- 8
About Global Vascular Co.
, Ltd. provides stunts used for the treatment of peripheral artery disease. The company was founded by Kenta Bito (CEO) and Shunto Maegawa., peripheral artery disease treatment medical device., sirolimus/biodegradable polymer coating, and BIOZONE Coating® a passive coating technology that enables high vessel scaffolding and drug-eluting capabilities as well as maintains a slim and non-obstructive profile for blood flow., Ltd. to conduct a pre-trial for its newly developed medical device.
Who invested in Global Vascular Co.
8 investors across 3 rounds
See all investors in Global Vascular Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Global Vascular Co.
Who invested in Global Vascular Co.?
Global Vascular Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Global Vascular Co. raised?
Global Vascular Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Global Vascular Co. last raise money?
Global Vascular Co.'s most recent round on record is a Series B, in Jun 2025.
What does Global Vascular Co. do?
Global Vascular Co. is a medical devices & equipment company.
Where is Global Vascular Co. headquartered?
Global Vascular Co. is headquartered in Tokyo, Japan.
Which VCs invest in companies like Global Vascular Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Global Vascular Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Global Vascular Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.